A high-content platform to characterise human induced pluripotent stem cell lines

Andreas Leha1, Nathalie Moens2, Ruta Meleckyte2

  • 1Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambridge CB10 1SD, UK.

Methods (San Diego, Calif.)
|November 27, 2015
PubMed
Summary

We developed a high-content platform to analyze human induced pluripotent stem cells (iPSCs). This tool quantifies phenotypic diversity, aiding disease modeling and drug discovery for iPSC therapies.